0001209191-23-024026.txt : 20230411 0001209191-23-024026.hdr.sgml : 20230411 20230411165918 ACCESSION NUMBER: 0001209191-23-024026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230410 FILED AS OF DATE: 20230411 DATE AS OF CHANGE: 20230411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conterno Enrique A CENTRAL INDEX KEY: 0001476151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 23813916 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-10 0 0000921299 FIBROGEN INC FGEN 0001476151 Conterno Enrique A C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-04-10 4 S 0 1869 19.52 D 382999 D Common Stock 27800 I By Trust Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. /s/ Cecelia Monoarfa-Taime, Attorney-in-fact 2023-04-11